These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25218810)

  • 1. Digital quantitation of HCC-associated stem cell markers and protein quality control factors using tissue arrays of human liver sections.
    Buzzanco A; Gomez A; Rodriguez E; French BA; Tillman BA; Chang S; Ganapathy E; Junrungsee S; Zarrinpar A; Agopian VG; Naini BV; French SW; French SW
    Exp Mol Pathol; 2014 Dec; 97(3):399-410. PubMed ID: 25218810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of stem cells in human liver diseases and hepatocellular carcinoma.
    Oliva J; French BA; Qing X; French SW
    Exp Mol Pathol; 2010 Jun; 88(3):331-40. PubMed ID: 20080086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
    Kim H; Park YN
    Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations and expression of PTEN and its relationship with cancer stem cell markers to investigate pathogenesis and to evaluate prognosis in hepatocellular carcinoma.
    Chen D; Li Z; Cheng Q; Wang Y; Qian L; Gao J; Zhu JY
    J Clin Pathol; 2019 Sep; 72(9):588-596. PubMed ID: 31126975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma.
    Ghanekar A; Ahmed S; Chen K; Adeyi O
    BMC Cancer; 2013 Oct; 13():485. PubMed ID: 24138671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells.
    Cheung PF; Cheng CK; Wong NC; Ho JC; Yip CW; Lui VC; Cheung AN; Fan ST; Cheung ST
    PLoS One; 2011; 6(12):e28246. PubMed ID: 22194816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
    Osada T; Sakamoto M; Nishibori H; Iwaya K; Matsuno Y; Muto T; Hirohashi S
    J Hepatol; 1997 Jun; 26(6):1266-73. PubMed ID: 9210613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.
    Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.
    Yilmaz G; Akyol G; Cakir A; Ilhan M
    Pathol Res Pract; 2014 Jul; 210(7):419-25. PubMed ID: 24702884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation.
    Kumagai A; Kondo F; Sano K; Inoue M; Fujii T; Hashimoto M; Watanabe M; Soejima Y; Ishida T; Tokairin T; Saito K; Sasajima Y; Takahashi Y; Uozaki H; Fukusato T
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):414-21. PubMed ID: 27161394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.
    Lingala S; Cui YY; Chen X; Ruebner BH; Qian XF; Zern MA; Wu J
    Exp Mol Pathol; 2010 Aug; 89(1):27-35. PubMed ID: 20511115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.
    Cheung PF; Cheung TT; Yip CW; Ng LW; Fung SW; Lo CM; Fan ST; Cheung ST
    Oncotarget; 2016 Apr; 7(16):21644-57. PubMed ID: 26942873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
    Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
    Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
    Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
    Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
    Jang JW; Song Y; Kim SH; Kim JS; Kim KM; Choi EK; Kim J; Seo HR
    Cancer Lett; 2017 Mar; 389():1-10. PubMed ID: 28034805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
    Shibuya M; Kondo F; Sano K; Takada T; Asano T
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
    Lequoy M; Desbois-Mouthon C; Wendum D; Gupta V; Blachon JL; Scatton O; Dumont S; Bonnemaire M; Schmidlin F; Rosmorduc O; Fartoux L
    Histopathology; 2017 Feb; 70(3):492-498. PubMed ID: 27391928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.